Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure

International Journal of Cardiology

Volumn 149, Issue 3, 2011, Pages 364-371

  Tasevska Dinevska, G ^a   Kennedy, L M ^a   Cline Iwarson, A ^b   Cline, C ^b   Erhardt, L ^a   Willenheimer, R ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B natriuretic peptide; Heart failure; Left ventricular ejection fraction and mass; Men; Peak oxygen consumption; Women

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART RATE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MITRAL VALVE REGURGITATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LUNG DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 79958127009     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.02.018     Document Type: Article

References (51)

1. Schocken DD, Arrietta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
2. Hochman JS, Tamis JE, Thompson TD, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999;341:226-32. (Pubitemid 29334520)
3. Petrie MC, Dawson NF, Murdoch DR, Davie AP, McMurray JJV. Failure of women's hearts. Circulation 1999;99:2334-41. (Pubitemid 29201142)
4. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993;22:6A-13A.
5. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121: 951-7.
6. Remes J, Miettinen H, Reunanen A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
7. Choi S, Park D, Lee S, Hong Y, Kim S, Lee J. Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments. Emerg Med J 2007;24:343-7. (Pubitemid 46696359)
8. Balion C, Santaquida PL, Hill S, et al. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure. Evid Rep Technol Assess 2006;142:1-147.
9. Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women. J Hypertens Suppl 2002;20:S34-8.
10. Vaccarino V, Chen Y, Wanf Y, Radford MJ, Krumholz HM. Sex differences in the clinical care and outcomes of congestive heart failure in the elderly. Am Heart J 1999;138:835-42. (Pubitemid 29523269)
11. Adams KF, Dunlap SH, Sueta CA, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781-8. (Pubitemid 26426235)
12. Daida H, Allison TG, Johnson BD, Squires RW, Gau GT. Comparison of peak exercise oxygen uptake in men versus women in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;80:85-8. (Pubitemid 27274587)
13. Pardaens K, Vanhaecke J, Fagdel RH. Impact of age and gender on peak oxygen uptake in chronic heart failure. Med Sci Sports Exerc 1997;29:733-7. (Pubitemid 27290732)
14. Hayward CS, Webb CM, Collins P. Effect of sex hormones on cardiac mass. Lancet 2001;357:1354-6. (Pubitemid 32441539)
15. Mair J, Hammarer-Lercher H, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin chem Lab Med 2001;39:571-88. (Pubitemid 32725741)
16. Vogelsang TW, Jensen RJ, Monrad AL, et al. Independent effects of both right and left ventricular function in plasma natriuretic peptide. Eur J Heart Fail 2007;9:892-6. (Pubitemid 47332315)
17. Kuster GM, Tanner H, Printzen G, Suter TM, Mohacsi P, Hess OM. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly 2002;132:623-8. (Pubitemid 36227539)
18. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-68. (Pubitemid 50011582)
19. Grewal J, Mckelvie R, Lorin E, et al. BNP and NT-pro BNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008;10:252-9. (Pubitemid 351343862)
20. Detaint D, Messike-Leitoum D, Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005;111:2391-7. (Pubitemid 40647075)
21. Krauser DG, Lloyd-Jones DM, Chae CU, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive failure: a Pro BNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2005;149:744-50.
22. Iwanaga Y, Kihara Y, Niizuma S, et al. BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship. J Card Fail 2007:13663-7.
23. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002;90:254-8. (Pubitemid 34804560)
24. DeFillipi C, van Kimmenade RR, Pinto YM. Amino-terminal proB-type natriuretic peptide testing in renal disease. Am J Cardiol 2008;101:82-8.
25. Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH. Plasma N-terminal pro B-type natriuretic peptide andmortality in typ 2 diabetes. Diabetologia 2006;49:2256-62. (Pubitemid 44359085)
26. Nybo M, Benn M, Mogelvang R, et al. Impact of hemoglobine on plasma pro-B-type natriuretic peptide concentrations in the general population. Clin Chem 2007;52:1921-7. (Pubitemid 350036036)
27. März W, Tiran B, Seelhorst U, et al. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. Clin Chem 2007;53:1075-83. (Pubitemid 46867524)
28. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. J Am Coll Cardiol 2005;46:838-44. (Pubitemid 41224808)
29. Mottram PM, Haluska BA, Marwick TH. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. Am Heart J 2004;14B:365-70. (Pubitemid 39092808)
30. Usui Y, Tomiyama H, Hashimoto H, et al. Plasma B-type natriuretic peptide level is associated with left ventricular hypertrophy among obstructive sleep apnoea patients. Hypertens 2008;26:117.23.
31. Kannel WB, D'Agostino RB, Silbershatz H, Belanger AJ, Wilson PWF, Levy D. Profile for estimating risk of heart failure. Arch Int Med 1999;159:1197-204. (Pubitemid 29269859)
32. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1604-6.
33. de Groote P, Dagorn J, Soudan B, Lanblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004;43:1584-9. (Pubitemid 38561337)
34. Francis DP, Shamim W, Davies LC, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J 2000;21:154-61.
35. Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801. (Pubitemid 34987553)
36. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation 2003;108:1554-9. (Pubitemid 37187780)
37. Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circkulation 2002;106:3079-84. (Pubitemid 35440292)
38. Litwin SE, Katz SE, Litwin CM, Morgan JB, Douglas PS. Gender differences in postinfarction left ventricular remodelling. Cardiology 1999;91:173-83. (Pubitemid 29454255)
39. Cleland JG, Swedbwrg K, Follarth F, Komajda M, Cohen-Solal A, Aquilar JC. The EuroHeart Failure Survey programme- a survey on the quality of care among patients with heart failure in Europé. Part 1: Patients characteristics and diagnosis. Eur Heart J 2003;24:442-63. (Pubitemid 36286187)
40. Tasevska-Dinevska G, Kennedy LM, Cline-Iwarson A, Cline C, Erhardt L, Willenheimer R. Gender aspects on survival among patients admitted to hospital with suspected or diagnosed heart failure. Scand Cardiovasc J 2008;10:1-9.
41. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
42. Gudmundsson P, Rydberg E, Winter R, Willenheimer R. Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol 2005;101:209-12. (Pubitemid 40637614)
43. Winter R, Gudmundsson P, Ericsson G, Willenheimer R. Left ventricular early diastolic inflow velocity and atrial ventricular plane down ward velocity: useful parameters to test diastolic function in the praxis? Diastolic parameters tested in a clinical setting. Eur J Echocardiogr 2001;2:126-31. (Pubitemid 32677334)
44. Wilson JR, Hanamanthu S, Chomsky DB, Davis SF. Relationship between exertional symptoms and functional capacity in patients with heart failure. J Am Coll Cardiol 1999;33:1943-7.
45. CIS bio International. SHINORIA BNP. Directional insert. Kit Catalog mai 1998, version 04.
46. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. (Pubitemid 34764819)
47. Tabet JY, Beauvais F, Thabut G, Tartiére JM, Logeart D, Cohen-Solal A. A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2003;10:267-72. (Pubitemid 37433491)
48. Ho KK, Andersson KM, Kannel WB, Grossman W, Levy D. Survival after onset of congestive heart failure in the Framingham Heart Study. Circulation 1993;88:107-15. (Pubitemid 23195439)
49. Tabassome S, Mary-Krause M, Funck-Brentano C, Jaillon P. On behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure; results from the Cardiac Insufficiency Bisoprolol Study (CIBIC II). Circulation 2001;103:375-80.
50. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and current practices in heart failure. J Am Coll Cardiol 1993;22:14A-9A.
51. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.